Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
04/2006
04/25/2006CA2194885C Substituted benzamidines, their preparation and their use as pharmaceutical compounds
04/20/2006WO2006041968A1 Reversed pyrimidinone compounds as calcilytics
04/20/2006WO2006041405A1 Substituted amino-pyrimidones and uses thereof
04/20/2006WO2006041404A1 Substituted amino-compounds and uses thereof
04/20/2006WO2006041119A1 Hydrazide derivatives
04/20/2006WO2006040666A1 Substituted n-alkylpyrimidinones
04/20/2006WO2006040649A1 Crystalline forms of 3-[5-chloro-4-[(2,4-difluorobenzyl) oxy]-6-oxopyrimidin-1(6h)-yl]-n-(2-hydroxyethyl)-4-methylbenzamide
04/20/2006WO2006040300A1 4-cycloalkyl-pyrimidine-2-carbonitrile derivatives
04/20/2006WO2006040177A1 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 recptor
04/20/2006WO2005115398A3 Hiv integrase inhibitors
04/20/2006US20060084809 Compounds as PDE IV and TNF-inhibitors
04/20/2006US20060084699 Antagonists of the B2 receptor of bradykinin; analgesics; hyperalgesia and major algesia; cancer; nontoxic; industrial scale; 5-[[(2,4-dichloro-3-methylphenyl)sulphonyl]methylamino]-N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-N-methyl-pentanamide
04/20/2006US20060084688 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
04/20/2006US20060084680 ((1S)-5-{2-[(3-methyl-7-propyl-1,2-benzisoxazol-6-yl)oxy]ethoxy}-2,3-dihydro-1H-inden-1-yl)acetic acid; diabetes, obesity, hyperlipidemia, and atherosclerotic diseases; hyperglycemia, hyperinsulinemia, impaired glucose tolerance, dyslipidemia, hypertriglyceridemia, and insulin resistance
04/20/2006US20060084657 Piperazine derivative
04/20/2006US20060084612 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors
04/20/2006US20060082294 Organic electroluminescence device and phenylenediamine derivative
04/20/2006DE102004049622A1 Novel para-sulfonamido-substituted 2-anilinopyrimidines are useful in a wide range of medicaments and as cell cycle kinase inhibitors or receptor tyrosine kinase inhibitors
04/20/2006CA2584081A1 Substituted biaryl quinolin-4-ylamine analogues
04/20/2006CA2583967A1 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
04/20/2006CA2581516A1 Quinazoline derivatives
04/20/2006CA2580497A1 Substituted n-alkylpyrimidinones
04/19/2006EP1646615A1 Pyrimidine derivatives as modulators of atp-binding cassette transporters
04/19/2006EP1646389A1 Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists
04/19/2006EP1534711B1 Phenyl-substituted pyrazolopyrimidines
04/19/2006EP1456183B1 Process for preparing 1-(carboxymethyl)-and 1-(aminocarbonyl)-pyrimidin-4-one derivates
04/19/2006EP1420784B1 Compounds effecting glucokinase
04/19/2006EP1296959B1 Methods and compositions utilizing quinazolinones
04/19/2006EP1253924B1 Nitrate salts of antimicrobial agents
04/19/2006EP1177176B1 Tri-aryl acid derivatives as ppar receptor ligands
04/19/2006EP1080726B1 Agents for relieving side effects
04/19/2006EP1064274B1 Benzenesulfonamide derivatives and their use as medicaments
04/19/2006EP0901474B1 Aryl pyrimidine derivatives
04/19/2006CN1761646A Cannabinoid receptor ligands
04/18/2006US7030214 Ureins derived from α, ω, diamino acids and process for their preparation
04/18/2006US7030161 α-and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
04/18/2006US7030139 Compounds
04/18/2006US7029835 Photothermographic element comprising improved base precursors and methods for their use
04/18/2006US7029654 anticoagulants either embedded in or physically linked to materials used in the manufacture of devices used in blood collection, blood circulation, and blood storage
04/18/2006CA2360943C N2-phenylamidine derivatives
04/13/2006WO2006038587A1 Binuclear metal complex, metal complex dye, photoelectric transducer and photochemical battery
04/13/2006WO2006037950A1 Method of deprotection
04/13/2006WO2006037496A1 Polyhalogenated propene benzoquinone dioxime derivatives and its use as pesticides
04/13/2006WO2006020070A3 Indanylamino uracils and their use as antioxidants and neuroprotectants
04/13/2006WO2005123694A3 Quinazolinone compounds for the treatment of cough
04/13/2006WO2005110416A3 4,5-disubstituted-2-aryl pyrimidines
04/13/2006WO2005007621A3 Ubiquitin ligase inhibitors
04/13/2006US20060079687 Novel 2-amino-quinazoline derivatives useful as inhibitors of beta-secretase (BACE)
04/13/2006US20060079686 Novel 2-amino-quinazoline derivatives useful as inhibitors of beta-secretase (BACE)
04/13/2006US20060079685 1-(4-Bromo-benzyl)-4-(4-isopropyl-phenyl)-6-propargyloxy-1H-quinazolin-2-one;osteoporosis, bone disorders, fractures, osteopathy, osteo-malacia, periodontal bone loss or bone loss due to arthritis or osteoarthritis; for promoting the release of parathyroid hormone
04/13/2006US20060079563 Cyclic protein tyrosine kinase inhibitors
04/13/2006US20060079561 Insecticidal anthranilamides
04/13/2006US20060078975 Crystal structure of enzyme and uses thereof
04/13/2006DE19525393B4 Chemisches Verfahren Chemical process
04/12/2006EP1644369A2 Arylamine-substituted quinazolinone compounds
04/12/2006EP1644357A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
04/12/2006EP1644343A1 5-substituted quinazolinone derivatives
04/12/2006EP1644342A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
04/12/2006EP1644341A1 Process of making di-aryl urea compounds
04/12/2006EP1644340A1 N-{'4-substituted piperazine-1-sulfonylmethyl]alkyl}-n-hydroxyformamide compounds as metalloproteinase inhibitors
04/12/2006EP1644339A1 6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors
04/12/2006EP1644338A1 2, 4, 6-trisubstituted pyrimidine derivatives useful for the treatment of neoplastic and autoimmune diseases
04/12/2006EP1644337A1 Melanocortin-4 receptor binding compounds and methods of use thereof
04/12/2006EP1643960A2 Arylsulfonamide derivatives
04/12/2006EP1418879B1 Oxidation hair dyes containing 3-aminophenol derivatives, and novel 3-aminophenol derivatives
04/12/2006EP1345920B1 Novel sulfamides and their use as endothelin receptor antagonists
04/12/2006EP1311499B1 Bicyclic compounds as h3 receptor ligands
04/12/2006EP1270017B1 Radiolabeled pyrimidine nucleoside for the diagnosis of tissue-reproductive activity
04/12/2006EP1254119B1 Pyrimidine derivatives as selective inhibitors of cox-2
04/12/2006CN1759105A Insecticidal phthalamide derivatives
04/12/2006CN1250735C Method for production of non-proteinogen L-amino acid by fermentation
04/12/2006CN1250559C Process for preparing amine platinum complexes
04/12/2006CN1250531C Novel compounds
04/11/2006US7026479 Process for the production of quinazolines
04/11/2006US7026478 Iron catalyzed cross coupling reactions of aromatic compounds
04/11/2006US7026328 Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins
04/11/2006US7026327 2-etherified 4-fluoroalkyl-6-(p-sulfonylphenyl)pyrimidines,e.g., 2-(4-fluorophenoxy)-4-[4-(methylsulfonyl)phenyl]-6](trifluoromethyl)pyrimidine; treatment of the pain, fever and inflammation of variety of conditions and diseases
04/11/2006US7026270 malayamycin A and desmethylmalayamycin A prepared from a previously unknown strain of Streptomyces malaysiensis, used for combating or controlling phytopathogenic fungi
04/11/2006US7025987 Delivery system for nucleic acids
04/11/2006US7025813 Ink composition containing a particular type of dye, and corresponding ink-jet printing process
04/11/2006CA2244897C 4-anilinoquinazoline derivatives
04/06/2006WO2006037117A1 Substituted heterocyclic compounds and methods of use
04/06/2006WO2006036625A2 Encapsulated pharmaceutical agents
04/06/2006WO2006035277A2 Novel processes for preparing amorphous rosuvastatin calcium and a novel polymorphic form of rosuvastatin sodium
04/06/2006WO2006035069A1 Hiv inhibiting 5-substituted pyrimidines
04/06/2006WO2006035068A2 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines
04/06/2006WO2006034872A1 Substituted 2-anilinopyrimidines as cell cycle kinase inhibitors or receptor tyrosine kinase inhibitors, production of said substances and use of the latter as medicaments
04/06/2006WO2005113554A3 Method of preparing 3-phenyl-2-[9h-purin-6-ylamino)-methyl]-3h-quinazolin-4-one and substituted and related compounds
04/06/2006WO2005061501A3 Process for preparing hexahydropyrimido[1,2-a]azepine-2-carboxylates and related compounds
04/06/2006US20060074111 Chemical compounds
04/06/2006US20060074110 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
04/06/2006US20060074092 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin K inhibitory activity for the treatment of inflammations and other diseases
04/06/2006US20060074068 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions
04/06/2006CA2580838A1 Substituted heterocyclic compounds and methods of use
04/06/2006CA2575472A1 Hiv inhibiting 5-substituted pyrimidines
04/06/2006CA2573976A1 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines
04/05/2006EP1641767A2 Bicyclic heterocycles, drugs containing said compounds, the use thereof and method for preparing the same
04/05/2006EP1641766A2 Novel chemical compounds
04/05/2006EP1641535A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
04/05/2006EP1641493A1 Radiolabeled cannabinoid-1 receptor modulators